The Cancer Letter

Inside information on cancer research and drug development

In the Archives

Presidents Day, Black History Month, Lasker Awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

This column in The Cancer Letter features the latest posts to the Cancer History Project by our growing list of contributors.

The Cancer History Project is a free, web-based, collaborative resource intended to mark the 50th anniversary of the National Cancer Act and designed to continue in perpetuity. The objective is to assemble a robust collection of historical documents and make them freely available.

Access to the Cancer History Project is open to the public at CancerHistoryProject.com. You can also follow us on Twitter at @CancerHistProj.

Upcoming

Finding the cure for childhood leukemia: On Feb. 24, a Buffalo Public Library panel featuring Jerry Yates, Mary Pinkel, and Cancer History Project editorial board member Tim Wendel.

Register in advance on Zoom.

Quote of the week

It is a great human weakness to generalize from exceptions. As scientists, we know that the best solution to a specific problem is a specific solution.

Emil J Freireich

Freireich’s Seven Laws To Protect Against Obstacles To Clinical Research
The Cancer Letter, May 14, 1976

Black History Month

jane-wright

A collection of posts celebrating the impact on oncology by Black, Indigenous, and People of Color oncologists, researchers, and advocates will continue to be available under the tag “BIPOC Impact.”

Presidents Day

These articles were highlighted on Presidents Day via @CancerHistProj on Twitter as part of a series on cancer in the White House.

Recent contributions

Is your institution a contributor to the Cancer History Project? Would you like us to tell you about the project and how you can get involved?

Eligible institutions include cancer centers, advocacy groups, professional societies, pharmaceutical companies, and key organizations in oncology. To apply to become a contributor, please contact admin@cancerhistoryproject.com.

Table of Contents

YOU MAY BE INTERESTED IN

Obituary

Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
By Melinda Krigel
Obituary

Feng’s team advanced the understanding of biomarkers in prostate cancer

The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.
By NRG Staff
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account